GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Danimer Scientific Inc (NYSE:DNMR) » Definitions » Cash Ratio

Danimer Scientific (Danimer Scientific) Cash Ratio : 3.76 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Danimer Scientific Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Danimer Scientific's Cash Ratio for the quarter that ended in Dec. 2023 was 3.76.

Danimer Scientific has a Cash Ratio of 3.76. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Danimer Scientific's Cash Ratio or its related term are showing as below:

DNMR' s Cash Ratio Range Over the Past 10 Years
Min: 0.18   Med: 3.76   Max: 7.48
Current: 3.76

During the past 5 years, Danimer Scientific's highest Cash Ratio was 7.48. The lowest was 0.18. And the median was 3.76.

DNMR's Cash Ratio is ranked better than
91.99% of 1549 companies
in the Chemicals industry
Industry Median: 0.53 vs DNMR: 3.76

Danimer Scientific Cash Ratio Historical Data

The historical data trend for Danimer Scientific's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danimer Scientific Cash Ratio Chart

Danimer Scientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
0.18 7.48 6.59 2.48 3.76

Danimer Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.48 4.12 6.22 5.24 3.76

Competitive Comparison of Danimer Scientific's Cash Ratio

For the Specialty Chemicals subindustry, Danimer Scientific's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danimer Scientific's Cash Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Danimer Scientific's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Danimer Scientific's Cash Ratio falls into.



Danimer Scientific Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Danimer Scientific's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=59.17/15.723
=3.76

Danimer Scientific's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=59.17/15.723
=3.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Danimer Scientific  (NYSE:DNMR) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Danimer Scientific Cash Ratio Related Terms

Thank you for viewing the detailed overview of Danimer Scientific's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Danimer Scientific (Danimer Scientific) Business Description

Traded in Other Exchanges
Address
140 Industrial Boulevard, Bainbridge, GA, USA, 39817
Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are 100% biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. The company holds more than 470 patents and pending patent applications in nearly 20 countries for a range of manufacturing processes and biopolymer formulations.
Executives
Richard J Hendrix director 1300 NORTH 17TH STREET, ARLINGTON VA 22209
Scott Tuten officer: Chief Marketing Officer 286 DOE RUN DRIVE, CAIRO GA 39828
Gregory W. Hunt director 730 5TH AVENUE, NEW YORK NY 10019
Allison Leopold Tilley director 1300 NORTH 17TH STREET, ARLINGTON VA 22209
Cynthia R Cohen director 1401 BRICKELL AVENUE, SUITE 640, C/O STRATEGIC MINDSHARE, MIAMI FL 33131
John P Amboian director
Michael A Hajost officer: Chief Financial Officer C/O CARPENTER TECHNOLOGY CORPORATION, PO BOX 14662, READING PA 19612-4662
Stephen Croskrey director, officer: CEO & Chairman of the Board C/O ARMOR HOLDINGS INC, 1400 MARSH LANDING PARKWAY SUITE 112, JACKSONVILLE FL 32250
Stuart W Pratt director 303 CONGRESS STREET, BOSTON MA 02210
Van Trump Phillip D officer: Chief Technology Officer 1466 NORTH DECATUR ROAD, ATLANTA GA 30306
Philip Gregory Calhoun director 2100 WHITES BRIDGE ROAD, COLQUITT GA 39837
Isao Noda director 1568 HUNTER ROAD, FAIRFIELD OH 45914
Michael Eric Smith officer: Chief Operating Officer 2208 WYNDHAM WAY, BAINBRIDGE GA 39819
Christy A Basco director 206 WINDING HOLLOW LANE, COPPELL TX 75019
Wunderlich Gary Kent Jr 10 percent owner, officer: President, other: President CLO B. RILEY FINANCIAL, INC.,, 21255 BURBANK BLVD., SUITE 400, WOODLAND CA 91367